checkAd
    Startseite > Aktien > Aerovate Therapeutics > Nachrichten
    Aerovate Therapeutics Aktie
    20,290
     
    USD
    -2,22 %
    -0,460 USD
    Letzter Kurs 02:00:00 Nasdaq
    20,220
     
    USD
    200 STK
    Geldkurs 03.05.24
    20,290
     
    USD
    700 STK
    Briefkurs 03.05.24
    ISIN: US0080641071 · WKN: A3CTMQ · SYM: AVTE · USA

    Neueste Nachrichten

    Aerovate Therapeutics to Present Patient Baseline Characteristics of the Phase 2b Portion of the Phase 2b/Phase 3 IMPAHCT Trial at the American Thoracic Society 2024 International Conference
    27.03.24 · globenewswire · Aerovate Therapeutics
    Aerovate Therapeutics Announces Full-Year 2023 Financial Results and Business Highlights
    25.03.24 · globenewswire · Aerovate Therapeutics
    Aerovate Therapeutics Board of Directors Appoints Habib Dable as Board Chair
    06.03.24 · globenewswire · Aerovate Therapeutics
    Aerovate Therapeutics Announces Simultaneous Completion of Enrollment in Phase 2b Portion and Enrollment of First Patient into Phase 3 in the IMPAHCT Trial Evaluating AV-101 for the Treatment of Pulmonary Arterial Hypertension
    20.11.23 · globenewswire · Aerovate Therapeutics
    Aerovate Therapeutics Announces Third Quarter Financial Results and Business Highlights
    13.11.23 · globenewswire · Aerovate Therapeutics
    Aerovate Therapeutics Announces Second Quarter Financial Results and Business Highlights
    14.08.23 · globenewswire · Aerovate Therapeutics
    Aerovate Therapeutics Appoints Habib Dable To Its Board of Directors
    11.07.23 · globenewswire · Aerovate Therapeutics
    Aerovate Therapeutics to Present at Jefferies Global Healthcare Conference
    01.06.23 · globenewswire · Aerovate Therapeutics
    Aerovate Therapeutics Presents Nonclinical Pharmacokinetic Data in Support of AV-101, a Novel Dry Powder Inhaled Formulation of Imatinib, at the American Thoracic Society (ATS) 2023 International Conference
    22.05.23 · globenewswire · Aerovate Therapeutics
    Aerovate Therapeutics Announces First Quarter Financial Results and Business Highlights
    15.05.23 · globenewswire · Aerovate Therapeutics